We are live on !
Find out more
RS
R Squared Portfolio holdings
AUM
$190M
Turnover
64%
1-Year Est. Return
25.89%
This Fund
S&P 500
This Quarter Est. Return
+15.51%
1 Year Est. Return
+25.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
+$8.35M
(+4.6%)
Cap. Flow
-$4.65M
Cap. Flow % of AUM
Cap. Flow %
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
14.08%
Holding
725
New
248
Increased
120
Reduced
140
Closed
216
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.3M |
| 2 |
Penumbra
PEN
|
+$2.89M |
| 3 |
Intuitive Surgical
ISRG
|
+$1.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.71M |
| 5 |
Costco
COST
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$5.96M |
| 2 |
Apple
AAPL
|
+$3.04M |
| 3 |
Micron Technology
MU
|
+$2.56M |
| 4 |
Eli Lilly
LLY
|
+$2.13M |
| 5 |
Visa
V
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.35% |
| 2 | Technology | 17.3% |
| 3 | Industrials | 15.96% |
| 4 | Healthcare | 11.59% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
OneWater Marine
ONEW
$156M
| $137K | 0.07% |
+12,162
| New | +$131K |
2026 Q2
0 quarters
|
|
377
Patria Investments
PAX
$1.92B
| $134K | 0.07% |
12,229
+1,621
| +15% | +$19.3K |
2025 Q2
4 quarters
|
|
378
Santander
BSBR
$41.3B
| $134K | 0.07% |
+25,468
| New | +$145K |
2026 Q2
0 quarters
|
|
379
Baytex Energy
BTE
$3.78B
| $133K | 0.07% |
33,200
-9,177
| -22% | -$42.4K |
2025 Q3
3 quarters
|
|
380
Tronox
TROX
$538M
| $133K | 0.07% |
21,054
+5,212
| +33% | +$44.2K |
2026 Q1
1 quarter
|
|
381
Lexicon Pharmaceuticals
LXRX
$690M
| $132K | 0.07% |
54,985
-12,541
| -19% | -$24.4K |
2025 Q2
4 quarters
|
|
382
JBS N.V.
JBS
$42.4B
| $132K | 0.07% |
11,112
+858
| +8% | +$12.5K |
2025 Q3
3 quarters
|
|
383
Ondas Inc
ONDS
$3.53B
| $131K | 0.07% |
15,922
-20,482
| -56% | -$202K |
2025 Q4
2 quarters
|
|
384
Lloyds Banking Group
LYG
$77.5B
| $129K | 0.07% |
+22,156
| New | +$120K |
2026 Q2
0 quarters
|
|
385
Lifecore Biomedical
LFCR
$242M
| $129K | 0.07% |
+24,580
| New | +$124K |
2026 Q2
0 quarters
|
|
386
Tilray
TLRY
$448M
| $125K | 0.07% |
27,861
+13,318
| +92% | +$76.2K |
2026 Q1
1 quarter
|
|
387
Maravai LifeSciences
MRVI
$1.04B
| $124K | 0.06% |
19,822
-7,572
| -28% | -$32.7K |
2025 Q4
2 quarters
|
|
388
Exagen
XGN
$180M
| $121K | 0.06% |
26,073
-1,034
| -4% | -$3.89K |
2025 Q4
2 quarters
|
|
389
Ardent Health
ARDT
$1.65B
| $120K | 0.06% |
12,193
-1,778
| -13% | -$16.9K |
2026 Q1
1 quarter
|
|
390
Nextdoor Holdings, Inc. Class A Common Stock
NXDR
$967M
| $119K | 0.06% |
52,595
+23,270
| +79% | +$43.4K |
2025 Q3
3 quarters
|
|
391
Asure Software
ASUR
$203M
| $118K | 0.06% |
14,897
+505
| +4% | +$4.4K |
2025 Q2
4 quarters
|
|
392
GeoPark
GPRK
$761M
| $117K | 0.06% |
+12,852
| New | +$125K |
2026 Q2
0 quarters
|
|
393
Inventiva
IVA
$704M
| $113K | 0.06% |
+29,918
| New | +$144K |
2026 Q2
0 quarters
|
|
394
Lifestance Health
LFST
$4.47B
| $111K | 0.06% |
+10,331
| New | +$79.8K |
2026 Q2
0 quarters
|
|
395
Iovance Biotherapeutics
IOVA
$6.44B
| $109K | 0.06% |
26,277
-606
| -2% | -$2.3K |
2025 Q2
4 quarters
|
|
396
1stdibs.com
DIBS
$143M
| $105K | 0.06% |
21,466
+8,852
| +70% | +$42.7K |
2026 Q1
1 quarter
|
|
397
Krispy Kreme
DNUT
$512M
| $105K | 0.06% |
29,757
-4,255
| -13% | -$15.2K |
2025 Q2
4 quarters
|
|
398
Arcos Dorados Holdings
ARCO
$1.67B
| $103K | 0.05% |
12,821
-296
| -2% | -$2.56K |
2024 Q4
6 quarters
|
|
399
FreightCar America
RAIL
$192M
| $103K | 0.05% |
+10,563
| New | +$89K |
2026 Q2
0 quarters
|
|
400
Patterson-UTI
PTEN
$4.6B
| $102K | 0.05% |
+11,136
| New | +$124K |
2026 Q2
0 quarters
|
|
Similar funds
EL
BFG
AFP
CCMR
CCC
IC
NI
CFG
R Squared's Q2 2026 Portfolio in Review
As of Q2 2026, R Squared held 725 positions worth $190M, up 4.6% from $182M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
R Squared's Q2 2026 filing shows 248 new, 120 increased, 140 reduced and 216 closed positions. Its largest new stake was Meta Platforms (Facebook): 2,795 shares worth $1.57M. The largest sale was Hologic, an estimated $5.96M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- R Squared's largest Q2 2026 buy was Meta Platforms (Facebook): 2,795 shares worth $1.57M.
- R Squared added most to NVIDIA in Q2 2026, an estimated $3.3M increase.
- R Squared's biggest Q2 2026 reduction was Apple, cutting an estimated $3.04M.
- R Squared fully exited Hologic in Q2 2026, selling an estimated $5.96M.
- R Squared's ten largest holdings make up 14% of its $190M portfolio in Q2 2026.
- R Squared opened 248 new positions and closed 216 in Q2 2026.
- R Squared's portfolio value rose 4.6% quarter-over-quarter to $190M.
Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.